Jamieson C[au] - Search Results

Year	Number of Results
1948	1
1952	1
1958	1
1964	1
1969	4
1970	5
1972	8
1973	7
1974	7
1975	3
1976	3
1977	2
1978	2
1979	5
1980	5
1981	1
1982	3
1983	8
1984	6
1985	4
1986	3
1987	5
1988	3
1989	4
1990	6
1991	7
1992	4
1993	10
1994	8
1995	5
1996	7
1997	4
1998	3
1999	8
2000	8
2001	5
2002	2
2003	7
2004	5
2005	6
2006	7
2007	5
2008	13
2009	11
2010	18
2011	8
2012	10
2013	11
2014	11
2015	19
2016	22
2017	15
2018	21
2019	27
2020	24
2021	31
2022	2

1

A First-in-Human, Phase I Study of Neural Stem Cell Transplantation for Chronic Spinal Cord Injury.

Curtis E, Martin JR, Gabel B, Sidhu N, Rzesiewicz TK, Mandeville R, Van Gorp S, Leerink M, Tadokoro T, Marsala S, Jamieson C, Marsala M, Ciacci JD. Curtis E, et al. Among authors: jamieson c. Cell Stem Cell. 2018 Jun 1;22(6):941-950.e6. doi: 10.1016/j.stem.2018.05.014. Cell Stem Cell. 2018. PMID: 29859175 Free article. Clinical Trial.

2

The hydrophobic rich N- and C-terminal tails of β-catenin facilitate nuclear import.

Sharma M, Jamieson C, Lui C, Henderson BR. Sharma M, et al. Among authors: jamieson c. J Biol Chem. 2015 Jul 24;290(30):18479. doi: 10.1074/jbc.A114.603209. J Biol Chem. 2015. PMID: 26209728 Free PMC article.

3

NEDD4 and NEDD4L regulate Wnt signalling and intestinal stem cell priming by degrading LGR5 receptor.

Novellasdemunt L, Kucharska A, Jamieson C, Prange-Barczynska M, Baulies A, Antas P, van der Vaart J, Gehart H, Maurice MM, Li VS. Novellasdemunt L, et al. Among authors: jamieson c. EMBO J. 2020 Feb 3;39(3):e102771. doi: 10.15252/embj.2019102771. Epub 2019 Dec 23. EMBO J. 2020. PMID: 31867777 Free PMC article.

4

Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption.

Mondala PK, Vora AA, Zhou T, Lazzari E, Ladel L, Luo X, Kim Y, Costello C, MacLeod AR, Jamieson CHM, Crews LA. Mondala PK, et al. Among authors: jamieson chm. Cell Stem Cell. 2021 Apr 1;28(4):623-636.e9. doi: 10.1016/j.stem.2020.12.017. Epub 2021 Jan 20. Cell Stem Cell. 2021. PMID: 33476575

5

Specific Armadillo repeat sequences facilitate β-catenin nuclear transport in live cells via direct binding to nucleoporins Nup62, Nup153, and RanBP2/Nup358.

Sharma M, Jamieson C, Johnson M, Molloy MP, Henderson BR. Sharma M, et al. Among authors: jamieson c. J Biol Chem. 2016 Feb 26;291(9):4342. doi: 10.1074/jbc.A111.299099. J Biol Chem. 2016. PMID: 26921412 Free PMC article. No abstract available.

6

Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy.

Shalapour S, Font-Burgada J, Di Caro G, Zhong Z, Sanchez-Lopez E, Dhar D, Willimsky G, Ammirante M, Strasner A, Hansel DE, Jamieson C, Kane CJ, Klatte T, Birner P, Kenner L, Karin M. Shalapour S, et al. Among authors: jamieson c. Nature. 2015 May 7;521(7550):94-8. doi: 10.1038/nature14395. Epub 2015 Apr 29. Nature. 2015. PMID: 25924065 Free PMC article.

7

BTS guidelines for the management of community acquired pneumonia in adults: update 2009.

Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, Macfarlane JT, Read RC, Roberts HJ, Levy ML, Wani M, Woodhead MA; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. Lim WS, et al. Among authors: jamieson c. Thorax. 2009 Oct;64 Suppl 3:iii1-55. doi: 10.1136/thx.2009.121434. Thorax. 2009. PMID: 19783532 No abstract available.

8

CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis.

Jaiswal S, Jamieson CH, Pang WW, Park CY, Chao MP, Majeti R, Traver D, van Rooijen N, Weissman IL. Jaiswal S, et al. Among authors: jamieson ch. Cell. 2009 Jul 23;138(2):271-85. doi: 10.1016/j.cell.2009.05.046. Cell. 2009. PMID: 19632178 Free PMC article.

9

Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial.

Mascarenhas J, Hoffman R, Talpaz M, Gerds AT, Stein B, Gupta V, Szoke A, Drummond M, Pristupa A, Granston T, Daly R, Al-Fayoumi S, Callahan JA, Singer JW, Gotlib J, Jamieson C, Harrison C, Mesa R, Verstovsek S. Mascarenhas J, et al. Among authors: jamieson c. JAMA Oncol. 2018 May 1;4(5):652-659. doi: 10.1001/jamaoncol.2017.5818. JAMA Oncol. 2018. PMID: 29522138 Free PMC article. Clinical Trial.

10

Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia.

Choi MY, Widhopf GF 2nd, Ghia EM, Kidwell RL, Hasan MK, Yu J, Rassenti LZ, Chen L, Chen Y, Pittman E, Pu M, Messer K, Prussak CE, Castro JE, Jamieson C, Kipps TJ. Choi MY, et al. Among authors: jamieson c. Cell Stem Cell. 2018 Jun 1;22(6):951-959.e3. doi: 10.1016/j.stem.2018.05.018. Cell Stem Cell. 2018. PMID: 29859176 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results